Literature DB >> 25382905

Safety and effectiveness of bubble continuous positive airway pressure in preterm neonates with respiratory distress.

S S Mathai1, A Rajeev2, K M Adhikari3.   

Abstract

BACKGROUND: Studies on Bubble Continuous Positive Airway Pressure (B-CPAP) as respiratory support for neonates are few. The aim of our study was to determine the efficacy and safety of B-CPAP in preterm neonates requiring respiratory support.
METHODS: A prospective observation study was done on 50 preterm babies requiring respiratory support for mild to moderate respiratory distress. Support was given with short, nasal cannulae. Surfactant was administered when indicated. Monitoring was done clinically, with pulse oximeter, radiologically and with blood gases. Staff members were also asked their views. Follow-up was done for 3 months.
RESULTS: The mean gestational age was 32.46 (+3.23) weeks and mean birth weight 1454.4 (+487.42) g. Respiratory Distress Syndrome was the commonest indication (30/50). The mean maximum pressure was 6.04 cm H2O and mean maximum FiO2 was 72.16%. Mean maximum paO2, paCO2 and mean minimum paCO2 were 92.93 mm Hg (+16.97), 52.36 mm Hg (+ 7.78) and 36.46 mm Hg (+ 4.95) respectively. Early initiation resulted in lesser duration of support. Failure rate was 30%. Apnoea, >1 dose surfactant and late initiation had a statistically higher incidence of failure. Main complications were skin abrasions (30%), feed intolerance (26%) and gastric distension (26%). Survival rate was 94%. 68% of staff felt that it was as easy to use and 88% felt it was more reliable than standard CPAP.
CONCLUSIONS: Bubble Continuous Positive Airway Pressure is safe, efficacious and easy to use in preterm neonates with mild to moderate respiratory distress.

Entities:  

Keywords:  Bubble; Continuous Positive Airway Pressure; Preterm; Respiratory distress

Year:  2014        PMID: 25382905      PMCID: PMC4223220          DOI: 10.1016/j.mjafi.2013.08.003

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  15 in total

1.  An evaluation of bubble-CPAP in a neonatal unit in a developing country: effective respiratory support that can be applied by nurses.

Authors:  Lanieta Koyamaibole; Joseph Kado; Josaia D Qovu; Samantha Colquhoun; Trevor Duke
Journal:  J Trop Pediatr       Date:  2005-12-02       Impact factor: 1.165

2.  Understanding the use of continuous oscillating positive airway pressure (bubble CPAP) to treat neonatal respiratory disease: an engineering approach.

Authors:  P I Manilal-Reddy; A M Al-Jumaily
Journal:  J Med Eng Technol       Date:  2009

3.  Variables associated with the early failure of nasal CPAP in very low birth weight infants.

Authors:  Amer Ammari; Mandhir Suri; Vladana Milisavljevic; Rakesh Sahni; David Bateman; Ulana Sanocka; Carrie Ruzal-Shapiro; Jen-Tien Wung; Richard A Polin
Journal:  J Pediatr       Date:  2005-09       Impact factor: 4.406

4.  Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure.

Authors:  G A Gregory; J A Kitterman; R H Phibbs; W H Tooley; W K Hamilton
Journal:  N Engl J Med       Date:  1971-06-17       Impact factor: 91.245

5.  Work of breathing during nasal continuous positive airway pressure in preterm infants: a comparison of bubble vs variable-flow devices.

Authors:  Ellina Liptsen; Zubair H Aghai; Kee H Pyon; Judy G Saslow; Tarek Nakhla; Jennifer Long; Andrew M Steele; Robert H Habib; Sherry E Courtney
Journal:  J Perinatol       Date:  2005-07       Impact factor: 2.521

6.  A randomized controlled trial of post-extubation bubble continuous positive airway pressure versus Infant Flow Driver continuous positive airway pressure in preterm infants with respiratory distress syndrome.

Authors:  Samir Gupta; Sunil K Sinha; Win Tin; Steven M Donn
Journal:  J Pediatr       Date:  2009-02-23       Impact factor: 4.406

7.  Is chronic lung disease in low birth weight infants preventable? A survey of eight centers.

Authors:  M E Avery; W H Tooley; J B Keller; S S Hurd; M H Bryan; R B Cotton; M F Epstein; P M Fitzhardinge; C B Hansen; T N Hansen
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

8.  Bubble continuous positive airway pressure, a potentially better practice, reduces the use of mechanical ventilation among very low birth weight infants with respiratory distress syndrome.

Authors:  Teresa Nowadzky; Alfonso Pantoja; John R Britton
Journal:  Pediatrics       Date:  2009-06       Impact factor: 7.124

9.  Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation.

Authors:  H Verder; P Albertsen; F Ebbesen; G Greisen; B Robertson; A Bertelsen; L Agertoft; B Djernes; E Nathan; J Reinholdt
Journal:  Pediatrics       Date:  1999-02       Impact factor: 7.124

10.  A study of the effect of nasal modes of ventilation on the incidence of gastro-oesophageal reflux in preterm neonates.

Authors:  Ss Mathai; Karuna Datta; Km Adhikari
Journal:  Med J Armed Forces India       Date:  2012-01-18
View more
  5 in total

1.  Letter to editor.

Authors:  Subhash Chandra Shaw; Anupama Chowdhary
Journal:  Med J Armed Forces India       Date:  2015-01

2.  Reply.

Authors:  S S Mathai
Journal:  Med J Armed Forces India       Date:  2015-01

3.  Treatment outcomes of Pumani bubble-CPAP versus oxygen therapy among preterm babies presenting with respiratory distress at a tertiary hospital in Tanzania-Randomised trial.

Authors:  Annette Baine Mwatha; Michael Mahande; Raimos Olomi; Beatrice John; Rune Philemon
Journal:  PLoS One       Date:  2020-06-30       Impact factor: 3.240

4.  Reducing preterm mortality in eastern Uganda: the impact of introducing low-cost bubble CPAP on neonates <1500 g.

Authors:  F Okello; E Egiru; J Ikiror; L Acom; Ksm Loe; P Olupot-Olupot; K Burgoine
Journal:  BMC Pediatr       Date:  2019-09-04       Impact factor: 2.125

5.  Outcome of Respiratory Distress in Neonates with Bubble CPAP at Neonatal Intensive Care Unit of a Tertiary Hospital.

Authors:  Sunil Raja Manandhar
Journal:  JNMA J Nepal Med Assoc       Date:  2019 Mar-Apr       Impact factor: 0.406

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.